Clinical trial · Interventional
Carina™ Surgical Platform for Minimal Radical Gastrectomy
Carina™ Platform - A Single-arm Study for Gastrectomy
NCT07113340CI-TRIAL-00093348active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the safety and effectiveness of the laparoscopic surgical system（Carina™ Surgical Platform, developed by Ronovo Surgical, Inc) for use in gastrectomy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Robotic Gastrectomy | — | UNRESOLVED | — |
| Stomach Neoplasms | Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Carina™ Surgical Platform, developed by Ronovo Surgical, Inc | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- robot group
- description
- Carina™ Surgical Platform, developed by Ronovo Surgical, Inc
- interventionNames
- Device: Carina™ Surgical Platform, developed by Ronovo Surgical, Inc
Primary outcomes (2)
- measure
- Incidence of Serious Complications
- timeFrame
- From the beginning of surgery until hospital discharge, up to 16 weeks
- description
- Any deviation from the expected postoperative recovery was considered an adverse event and was classified according to the Clavien-Dindo complication grading system. Only complications of grade III or above were included in the analysis.
- measure
- Rate of No Surgical Conversion
- timeFrame
- From the start of surgery to the end of surgery, up to 5 hours
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Age between 18 and 80 years, any gender * Patients with gastric cancer planned to undergo laparoscopic surgery assisted by the laparoscopic surgical system * Agree to participate in this study and voluntarily sign the informed consent form * Willing to cooperate with study follow-up and related examinations Exclusion Criteria: * BMI \< 18.5 kg/m² or BMI ≥ 30 kg/m² * Patients with severe cardiovascular diseases who cannot tolerate laparoscopic surgery * Patients with severe respiratory diseases who cannot tolerate laparoscopic surgery * Patients with severe coagulation disorders who cannot tolerate laparoscopic surgery * Patients with a history of abdominal or pelvic surgery, radiotherapy, or chemotherapy who are not suitable for laparoscopic surgery * Pregnant or breastfeeding women * Patients currently participating in other drug or medical device clinical trials * Patients deemed unsuitable for participation in this study by the investigator
References
Publications (0)
Data not yet available
No reference posted for this study.